发明人陈志强,李文辉,胡光. "一种仑伐替尼杂质91的合成方法" [P]. 中国发明专利, 专利号 CN 116178750 A, 授权公告日 2021-06-25.
Yamamoto T, Brown S R, Anderson J P. "Method for the Synthesis of Lenvatinib Impurity 91" [P]. US Patent, US 11273668 B2, 2018-11-17.
Jørgensen K, Johansson L, Nowak P. "A Process for Preparing High-Purity Lenvatinib Impurity 91" [P]. European Patent, EP 3136030 A1, 2016-08-16.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 仑伐替尼杂质91 in Pharmaceutical Formulations". J. Nat. Prod., 2012, 1267, 9975-9994.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 仑伐替尼杂质91 as an Impurity". Biomed. Chromatogr., 2021, 1387, (11), 8890-8895.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Lenvatinib Impurity 91 Using HRMS and NMR". J. Agric. Food Chem., 2019, 1061, (12), 9945-9955.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate 仑伐替尼杂质91 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2013, 1137, (4), 5307-5319.